Deoxyribozyme sensor-based diagnostics for Mycobacterium tuberculosis

基于脱氧核酶传感器的结核分枝杆菌诊断

基本信息

项目摘要

DESCRIPTION (provided by applicant): The impact of Mycobacterium tuberculosis (Mtb) on global health is staggering, with ~2 million deaths and ~10 million new cases of tuberculosis (TB) each year. A major contributor to this crisis is the lack of effective point- of-care (POC) diagnostic tools for the detection of active TB disease. This compromises the ability of clinicians to make critical decisions regarding hospitalization, isolation, and treatment. As a result, undiagnosed patients progress to more severe disease and continue to transmit the infection. To make matters worse, efforts to treat TB, which currently involves a 6-9 month multi-drug regimen, are complicated by the increasing incidence of multidrug resistant TB (MDR-TB). Although rapid and accurate drug susceptibility testing (DST) is crucial for the control of active TB, an inexpensive POC diagnostic tool for DST in resource-limited settings is sorely lacking. The goal of this project is to exploit the unique properties of two-component deoxyribozyme (DNAzyme) sensors - high specificity and sensitivity, low cost, feasible implementation in resource-limited settings - to dramatically improve Mtb diagnostic capabilities. In Aim 1, we will design and optimize DNAzyme sensors capable of ultrasensitive, species-specific detection of Mtb RNA directly in sputum samples. In Aim 2, we will apply a similar technology to detect selected single nucleotide polymorphisms (SNPs), mutations that are known to confer resistance to clinically relevant antibiotics. Ultimately, we would seek to combine these two tools to create a novel comprehensive Mtb diagnostic platform. This technology has the potential to significantly improve TB diagnostic capabilities by providing a low-cost, sensitive, and highly specific POC assay that could be implemented in resource limited, high-incidence settings.
描述(申请人提供):结核分枝杆菌(Mtb)对全球健康的影响令人震惊,每年约有200万人死亡,约1000万新结核病(TB)病例。这场危机的一个主要原因是缺乏有效的护理点(POC)诊断工具来检测活动性结核病。这损害了临床医生的能力 做出关于住院、隔离和治疗的关键决定。因此,未确诊的患者会进展为更严重的疾病,并继续传播感染。更糟糕的是,目前涉及6-9个月多药方案的结核病治疗努力因耐多药结核病(MDR-TB)发病率的增加而变得复杂。尽管快速和准确的药敏试验(DST)对于控制活动性结核病至关重要,但在资源有限的情况下,用于DST的廉价POC诊断工具严重缺乏。该项目的目标是利用双组分脱氧核酶(DNAzyme)传感器的独特特性-高特异性和敏感度、低成本、在资源有限的情况下可行的实施-来显著提高结核分枝杆菌的诊断能力。在目标1中,我们将设计和优化能够在痰样本中直接检测Mtb RNA的超灵敏、特定物种的DNAzyme传感器。在目标2中,我们将应用类似的技术来检测选定的单核苷酸多态(SNPs),这些突变已知会导致对临床相关抗生素的耐药性。最终,我们将寻求将这两个工具结合起来 打造新型综合结核诊断平台。这项技术具有显著提高结核病诊断能力的潜力,它提供了一种可以在资源有限、高发环境中实施的低成本、高灵敏度和高特异性的POC检测方法。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA Computing Systems Activated by Electrochemically-triggered DNA Release from a Polymer-brush-modified Electrode Array.
DNA计算系统是由电化学触发的DNA从聚合物刷子修饰的电极阵列释放而激活的。
  • DOI:
    10.1002/elan.201600389
  • 发表时间:
    2017-03
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Gamella M;Zakharchenko A;Guz N;Masi M;Minko S;Kolpashchikov DM;Iken H;Poghossian A;Schöning MJ;Katz E
  • 通讯作者:
    Katz E
Nonequilibrium Hybridization Enables Discrimination of a Point Mutation within 5-40 °C.
  • DOI:
    10.1021/jacs.6b05628
  • 发表时间:
    2016-10-19
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Stancescu M;Fedotova TA;Hooyberghs J;Balaeff A;Kolpashchikov DM
  • 通讯作者:
    Kolpashchikov DM
Split Spinach Aptamer for Highly Selective Recognition of DNA and RNA at Ambient Temperatures.
Divide and control: split design of multi-input DNA logic gates.
DNA Antenna Tile-Associated Deoxyribozyme Sensor with Improved Sensitivity.
  • DOI:
    10.1002/cbic.201600438
  • 发表时间:
    2016-11-03
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Cox, Amanda J.;Bengtson, Hillary N.;Gerasimova, Yulia V.;Rohde, Kyle H.;Kolpashchikov, Dmitry M.
  • 通讯作者:
    Kolpashchikov, Dmitry M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dmitry Mikhaylovich Kolpashchikov其他文献

Dmitry Mikhaylovich Kolpashchikov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dmitry Mikhaylovich Kolpashchikov', 18)}}的其他基金

A Binary Probe-Based DNAzyme Cascade for Rapid Detection of MRSA/MSSA
用于快速检测 MRSA/MSSA 的基于二元探针的 DNAzyme 级联
  • 批准号:
    8314592
  • 财政年份:
    2012
  • 资助金额:
    $ 43万
  • 项目类别:
Nucleic acid analysis using deoxyribozyme technology
使用脱氧核酶技术进行核酸分析
  • 批准号:
    7870705
  • 财政年份:
    2006
  • 资助金额:
    $ 43万
  • 项目类别:
Nucleic acid analysis using deoxyribozyme technology
使用脱氧核酶技术进行核酸分析
  • 批准号:
    7282750
  • 财政年份:
    2006
  • 资助金额:
    $ 43万
  • 项目类别:
Nucleic acid analysis using deoxyribozyme technology
使用脱氧核酶技术进行核酸分析
  • 批准号:
    7131572
  • 财政年份:
    2006
  • 资助金额:
    $ 43万
  • 项目类别:
Nucleic acid analysis using deoxyribozyme technology
使用脱氧核酶技术进行核酸分析
  • 批准号:
    8146799
  • 财政年份:
    2006
  • 资助金额:
    $ 43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了